CDC recommends 2026-2027 COVID vaccine for adults and some children
The U.S. Centers for Disease Control and Prevention issued clinical considerations confirming that its prior guidance remains in effect for the 2026–2027 season, recommending a COVID-19 shot for all adults ages 18 and older, as well as for children ages 6 months to 17 years who are immunocompromised.
-
Key Clinical Takeaways:
- The CDC recommends the updated 2026-2027 COVID-19 vaccine for all adults ages 18 and older, and for immunocompromised children ages 6 months to 17 years.
- The American Academy of Family Physicians and other major medical groups advise universal vaccination for children ages 6 to 23 months, creating a slight variance with federal guidance.
- Following official CDC recommendations for groups outside the Food and Drug Administration’s precise approval scope can result in an “off-label” vaccination, though major health insurers continue covering recommended doses.
Federal Health Agencies Issue Distinct Clinical Guidance
Following a September 23 update, the CDC’s recommendations diverge slightly from the Food and Drug Administration’s approvals. While the CDC recommends vaccination for all adults, other medical organizations advise broader coverage for children. A September 25 update published in JAMA notes that major groups including the American Academy of Family Physicians recommend universal vaccination for children ages 6 to 23 months and endorse a risk-based approach for children ages 2 to 18 years. Because the CDC recommendations extend beyond what is technically approved by the FDA, following them can mean receiving a shot that is classified as “off-label.”
Frederic Bertley, an immunologist and vaccine educator, explains that the two agencies have different roles, with the FDA evaluating safety and efficacy for specific populations while the CDC develops clinical recommendations. Frederic Bertley points out that respiratory vaccines reduce severe illness and hospitalization rather than preventing every infection.
Healthy Adults and High Risk Patients Need Vaccination
For healthy adults ages 18 and older, vaccination is recommended. Samantha Picking, senior director of immunizations at Walgreens, notes that protection from past vaccination or infection decreases over time as the virus continues to change.
For individuals at higher risk of developing severe illness, protection remains essential. Majd Alsoubani, an infectious disease physician at Tufts Medical Center, observes that some people may not view themselves as high risk because they feel well and manage their medical conditions successfully.
Insurance Plans Cover Updated Vaccines Through 2027
National pharmacies are providing updated COVID-19 vaccines, though pharmacy rules remain subject to state law and local restrictions. Insurers continue to support patient access, as demonstrated by a May 2026 statement from AHIP indicating that member health plans would continue covering recommended vaccines through the end of 2027. Samantha Picking confirms that vaccines are generally available at no cost through most private insurance plans, Medicare, and Medicaid.
COVID-19 vaccines are available in the U.S. for the 2026–2027 season, formulated to target XFG. Adults ages 65 and older should receive two doses spaced six months apart. Samantha Picking recommends receiving the vaccination in the fall before respiratory-virus activity increases, though individuals who recently had COVID should consider waiting up to three months after symptom onset.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.